Skip to main content

Due to a building issue, the reception area in our Springfield office is temporarily closed. We are not able to assist walk-in visitors today (4/24) and tomorrow (4/25). An update will be provided when the reception area reopens. Be sure to check before traveling to our Springfield office.

WEBSITE ALERT: IDFPR is no longer affiliated with the idfpr[.]com domain name. The website currently hosted on that domain is not authorized by IDFPR and may pose a security threat to visitors. Please be sure to use only IDFPR’s official website at IDFPR.illinois.gov.

Mario Treto, Jr., Secretary

Updated IDFPR Statement on Recent Court Rulings About Mifepristone

News Release – Monday, May 1, 2023

On Friday, April 21, 2023, the United States Supreme Court stayed the Texas court ruling which had stayed the 2000 FDA approval of Mifepristone pending litigation on the merits. The U.S. Supreme Court ruling means that Mifepristone remains a legal reproductive healthcare option for women in Illinois, as well as across the nation. The Illinois Department of Financial and Professional Regulation (“IDFPR”) will not discipline physicians who prescribe or pharmacists who fulfill prescriptions of Mifepristone.

Please click here to read the IDFPR statement.

Footer

Contact Information

Chicago Office
555 West Monroe Street, 5th Floor
Chicago, IL 60661

Springfield Office
320 West Washington Street, 3rd Floor
Springfield, IL 62786

Call Us: 1 (888) 473-4858

TTY/TDD Line: 1 (866) 325-4949

Stay Informed

Helpful Links